Form 4 for NRXP NRX Pharmaceuticals, Inc.
Accepted 2022-08-02 00:00:00 ET · period of report 2022-07-29 · accession 0000880984-22-000009 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2022-08-02 | 2022-07-29 | NRXP | Javitt Daniel C. | 10% | S - Sale | $1.01 | -784.1K | 9.87M | -7% | -$791.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-07-29 | S | D | 784,063 | $1.01 | 9,872,901 | I by Glytech LLC | — | — | (F1) Held by Glytech LLC of which the Reporting Person is the sole owner. |